NEOVISTA
NeoVista Inc is dedicated to the development of medical technologies that help to advance the treatment of wet age-related macular degeneration (AMD). Wet AMD affects more than 5 million people around the world and is a major cause of blindness in men and women over the age of 50. The unique technology being developed by NeoVista continues to show promise in clinical studies. It is our goal to help improve the quality of care and reduce the burden of this destructive condition on patients, physicians, and the healthcare system.
NEOVISTA
Industry:
Health Care Health Diagnostics Medical Device
Founded:
2002-01-01
Address:
Newark, California, United States
Country:
United States
Website Url:
http://www.neovistainc.com
Total Employee:
11+
Status:
Closed
Contact:
510-933-7600
Email Addresses:
[email protected]
Total Funding:
156.9 M USD
Technology used in webpage:
Energy Group Hosting
Current Advisors List
Current Employees Featured
Founder
Investors List
MPM Capital
MPM Capital investment in Venture Round - NeoVista
The Carlyle Group
The Carlyle Group investment in Venture Round - NeoVista
Accuitive Medical Ventures
Accuitive Medical Ventures investment in Venture Round - NeoVista
Essex Woodlands Healthcare Partners
Essex Woodlands Healthcare Partners investment in Venture Round - NeoVista
Versant Ventures
Versant Ventures investment in Venture Round - NeoVista
GE Capital
GE Capital investment in Debt Financing - NeoVista
Oxford Finance LLC
Oxford Finance LLC investment in Debt Financing - NeoVista
The Carlyle Group
The Carlyle Group investment in Series E - NeoVista
Versant Ventures
Versant Ventures investment in Series E - NeoVista
MPM Capital
MPM Capital investment in Series E - NeoVista
More informations about "NeoVista"
NeoVista - Crunchbase Company Profile & Funding
NeoVista Inc is dedicated to the development of medical technologies that help to advance the treatment of wet age-related macular degeneration (AMD). Wet AMD affects more than 5 …See details»
NeoVista - ContactOut
NeoVista Inc is dedicated to the development of medical technologies that help to advance the treatment of wet age-related macular degeneration (AMD). Wet AMD affects more than 5 …See details»
NeoVista , Inc. Information - RocketReach
NeoVista , Inc. is a Medical Devices & Equipment, Health Care, and Manufacturing company located in Newark, California with $4.6 million in revenue and 0 employees. Find top …See details»
NeoVista, Inc. | The Carlyle Group
NeoVista, Inc. is a developer of device-based therapy for age-related macular degeneration (AMD), the leading cause of blindness in older Americans. Fremont , CA U.S.See details»
NeoVista, Inc.: Drug pipelines, Patents, Clinical trials - Synapse
Jun 21, 2023 · Explore NeoVista, Inc. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials.See details»
NeoVista | Company | Mindmaps
NeoVista Inc is dedicated to the development of medical technologies that help to advance the treatment of wet age-related macular degeneration (AMD).See details»
NeoVista - Products, Competitors, Financials, Employees, …
NeoVista focuses on the development of medical technologies. It specializes in advancing the treatment of wet age-related macular degeneration (AMD) through innovative medical devices. …See details»
Neovista, INC | (510) 933-7600 | Newark, California - AllBiz
Neovista, INC is located in Newark, California, and was founded in 2002. Annual sales for Neovista, INC are around USD 500,000 - 999,999.See details»
The Innovation Factory - tif.net
NeoVista is developing a radiation therapy device for treating of the wet form of Age-related Macular Degeneration (ARMD), one of the leading causes of blindness in the world. NeoVista …See details»
NeoVista – Funding, Valuation, Investors, News | Parsers VC
May 14, 2021 · Information about NeoVista is updated every day. NeoVista valuation, number of raised finances, contact details, names of founders, latest news.See details»
NeoVista, Inc. Presents One Year Data on Novel Wet AMD Therapy
PALM BEACH, Fla., March 28 /PRNewswire/ -- NeoVista, Inc. released today to the eye community updated results from a one-year feasibility study of the company’s novel epiretinal …See details»
NeoVista, Inc. First European Patient Treated in CABERNET
LEIPZIG, Germany, November 29 /PRNewswire/ -- NeoVista, Inc. announced today that the first European patient has been treated in the company's pivotal global clinical trial for its novel …See details»
NeoVista , Inc. Asset Profile | Preqin
NeoVista , Inc., is based in Newark, US and operates as a developer of medical technologies for the treatment of wet age-related macular degeneration.See details»
FDA Grants NeoVista, Inc.'s Request to Expand CABERNET Trial
FREMONT, Calif., April 17 /PRNewswire/ -- NeoVista, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted the company's request to expand the number of …See details»
NeoVista®, Inc. Completes Enrollment in Pivotal CABERNET™ Study
Oct 25, 2009 · Fremont, CA (PRWEB) October 22, 2009-- NeoVista, Inc. today announced the completion of enrollment in its global 450-patient randomized controlled study of their …See details»
NeoVista, Inc. Unveils 18-month Data on Novel Wet AMD
SCOTTSDALE, Ariz., Sept. 29 /PRNewswire/ -- NeoVista, Inc. made public yesterday 18-month data from the company's Phase II feasibility study examining its novel epiretinal brachytherapy …See details»
NeoVista, Inc. Presents One Year Data On Novel Wet AMD Therapy
Mar 31, 2008 · NeoVista, Inc. released today to the eye community updated results from a one-year feasibility study of the company's novel epiretinal brachytherapy for the wet form of age …See details»
EW Healthcare Partners News - NeoVista Sticks with Insiders for …
Www.neovistainc.com. By Jonathan Matsey, VentureWire. Recent News. In Memoriam: Olivier Bohuon; Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership …See details»
NeoVista, Inc. Presents One Year Data on Novel Wet AMD Therapy
PALM BEACH, Fla., March 28 /PRNewswire/ -- NeoVista, Inc. released today to the eye community updated results from a one-year feasibility study of the company's novel epiretinal …See details»
NeoVista, Inc. Presents New Data on Its Novel Wet AMD
Nov 13, 2007 · NeoVista, Inc. Presents New Data on Its Novel Wet AMD Therapy at AAO One-Year Data Provides Ophthalmologists Critical Insight on Novel Beta Radiation Epiretinal TherapySee details»